Flixotide Inhaler 125 mikrograma po potisku, stlačeni inhalat, suspenzija
| Name | Flixotide Inhaler 125 mikrograma po potisku, stlačeni inhalat, suspenzija |
|---|---|
| Marketing Authorisation Number | HR-H-145522875 |
| Active Substance | flutikazonpropionat |
| Composition | jedna odmjerena doza (potiskom preko ventila) sadrži 125 mikrograma flutikazonpropionata |
| Pharmaceutical Form | stlačeni inhalat, suspenzija |
| Manufacturer | Glaxo Wellcome Production, Evreux, Francuska Glaxo Wellcome S.A., Aranda de Duero, Burgos, Španjolska |
| Marketing Authorisation Holder | GlaxoSmithKline Trading Services Limited, 12 Riverwalk, Citywest Business Campus, Dublin 24, Irska |
| Marketing Authorisation Date | 20.08.2021 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/17-02/828 |
| Registration Number | 381-12-01/70-21-11 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | ponovljivi recept |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | R03BA05 |
| Marketing status | stavljeno u promet |
| Shortage status | u tijeku |
| SmPC | download |
| PL | download |
